Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in...

Kicking off in Denver this year, one of the largest open source events in North America will bring together thousands of open source enthusiasts SAN FRANCISCO, April 3, 2025 /PRNewswire/ -- The...

24 scientific abstracts reflect UCB's ongoing commitment to improving outcomes for people living with neurological conditions, including rare epilepsies Dravet syndrome and Lennox-Gastaut...

The OpenSSL Corporation and the OpenSSL Foundation are proud to announce the OpenSSL Conference 2025, taking place from October 7 to 9, 2025, in Prague, Czech Republic, at the Vienna House by...

Independent Medical Alliance Annual Conference Spotlights Growing List of Federal & State-Level Victories WASHINGTON, April 2, 2025 /PRNewswire/ -- As the Independent Medical Alliance (IMA)...